Speaker illustration

Doctor Gisle Langslet

Oslo University Hospital Rikshospitalet, Oslo (Norway)

Cardiovascular outcomes according to LDL cholesterol levels in EMPA-REG OUTCOME

Event: ESC Congress 2016

Topic: Drug therapy

Session: A perspective on the effects of Empaglifozin in cardiovascular outcomes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb